The United States Continuous Glucose Monitoring Sales Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Continuous Glucose Monitoring Sales Market By Application
- Home Healthcare
- Hospitals
- Diagnostic Clinics
- Ambulatory Surgical Centers
- Others
Continuous Glucose Monitoring (CGM) systems in the United States find diverse applications across various sectors. In the realm of home healthcare, CGM devices enable individuals with diabetes to monitor their glucose levels continuously, providing real-time data for better management of their condition. Hospitals utilize CGM systems primarily in intensive care units and for hospitalized patients requiring close glucose monitoring. Diagnostic clinics also benefit significantly from CGM technology, using it to offer precise diagnostic services and continuous monitoring for patients under observation.
Ambulatory surgical centers integrate CGM devices during surgical procedures where monitoring glucose levels in real-time is crucial for patient safety and management of glucose levels throughout the procedure. Other applications include research institutions and academic medical centers, where CGM systems are used in studies and clinical trials to gather data on glucose trends and patterns in diverse patient populations.